These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 24862662)

  • 21. Risk factors for local recurrence following lateral neck dissection for papillary thyroid carcinoma.
    Raffaelli M; De Crea C; Sessa L; Tempera SE; Belluzzi A; Lombardi CP; Bellantone R
    Endocrine; 2019 Feb; 63(2):310-315. PubMed ID: 30341706
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prophylactic Central Neck Dissection Might Not Be Necessary in Papillary Thyroid Carcinoma: Analysis of 11,569 Cases from a Single Institution.
    Kim SK; Woo JW; Lee JH; Park I; Choe JH; Kim JH; Kim JS
    J Am Coll Surg; 2016 May; 222(5):853-64. PubMed ID: 27113516
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predictive factors of contralateral paratracheal lymph node metastasis in unilateral papillary thyroid carcinoma.
    Wei T; Chen R; Zou X; Liu F; Li Z; Zhu J
    Eur J Surg Oncol; 2015 Jun; 41(6):746-50. PubMed ID: 25882035
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The extent of lymph node yield in central neck dissection can be affected by preoperative and intraoperative assessment and alter the prognosis of papillary thyroid carcinoma.
    Hu JQ; Wen D; Ma B; Zhang TT; Liao T; Shi X; Wang YL; Zhu YX; Wang Y; Wei WJ; Ji QH
    Cancer Med; 2020 Feb; 9(3):1017-1024. PubMed ID: 31854077
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comprehensive Lateral Neck Dissection in Papillary Thyroid Carcinoma may Reduce Lateral Neck Recurrence Rates.
    Strajina V; Dy BM; McKenzie TJ; Al-Hilli Z; Ryder M; Farley DR; Thompson GB; Lyden ML
    Ann Surg Oncol; 2019 Jan; 26(1):86-92. PubMed ID: 30411267
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Outcomes for patients with papillary thyroid cancer who do not undergo prophylactic central neck dissection.
    Nixon IJ; Wang LY; Ganly I; Patel SG; Morris LG; Migliacci JC; Tuttle RM; Shah JP; Shaha AR
    Br J Surg; 2016 Feb; 103(3):218-25. PubMed ID: 26511531
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic significance of extranodal extension of regional lymph node metastasis in papillary thyroid cancer.
    Wu MH; Shen WT; Gosnell J; Duh QY
    Head Neck; 2015 Sep; 37(9):1336-43. PubMed ID: 24821456
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Elective central compartment neck dissection in patients with papillary thyroid carcinoma recurrence.
    Trivizki O; Amit M; Fliss DM; Gil Z
    Laryngoscope; 2013 Jun; 123(6):1564-8. PubMed ID: 23483525
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Optimal extent of prophylactic central neck dissection for papillary thyroid carcinoma: Comparison of unilateral versus bilateral central neck dissection.
    Yoo HS; Shin MC; Ji YB; Song CM; Lee SH; Tae K
    Asian J Surg; 2018 Jul; 41(4):363-369. PubMed ID: 28454667
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mapping the distribution of nodal metastases in papillary thyroid carcinoma: Where exactly are the nodes?
    Goyal N; Pakdaman M; Kamani D; Caragacianu D; Goldenberg D; Randolph GW
    Laryngoscope; 2017 Aug; 127(8):1959-1964. PubMed ID: 28271511
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Does the T1 subdivision correlate with the risk of recurrence of papillary thyroid cancer?
    Chereau N; Trésallet C; Noullet S; Godiris-Petit G; Tissier F; Leenhardt L; Menegaux F
    Langenbecks Arch Surg; 2016 Mar; 401(2):223-30. PubMed ID: 26957089
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prophylactic central neck dissection for papillary thyroid cancer.
    Barczyński M; Konturek A; Stopa M; Nowak W
    Br J Surg; 2013 Feb; 100(3):410-8. PubMed ID: 23188784
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinicopathological features of recurrent papillary thyroid cancer.
    Zhu J; Wang X; Zhang X; Li P; Hou H
    Diagn Pathol; 2015 Jul; 10():96. PubMed ID: 26168921
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Routine prophylactic central neck dissection for low-risk papillary thyroid cancer is not cost-effective.
    Garcia A; Palmer BJ; Parks NA; Liu TH
    Clin Endocrinol (Oxf); 2014 Nov; 81(5):754-61. PubMed ID: 24862564
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Level I lymph node involvement in patients with N1b papillary thyroid carcinoma: a prospective study.
    Eweida AM; Sakr MF; Hamza Y; Khalil MR; Gabr E; Koraitim T; Al-Wagih HF; Abo-Elwafa W; Ezzat Abdel-Aziz T; Diab AA; El-Sabaa B; Nabawi AS
    Eur Arch Otorhinolaryngol; 2017 Apr; 274(4):1951-1958. PubMed ID: 27999997
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Systematic evaluation of prophylactic neck dissection for the treatment of papillary thyroid carcinoma.
    Zhu W; Zhong M; Ai Z
    Jpn J Clin Oncol; 2013 Sep; 43(9):883-8. PubMed ID: 23858039
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pathologic features of metastatic lymph nodes identified from prophylactic central neck dissection in patients with papillary thyroid carcinoma.
    Lee HS; Park C; Kim SW; Noh WJ; Lim SJ; Chun BK; Kim BS; Hong JC; Lee KD
    Eur Arch Otorhinolaryngol; 2016 Oct; 273(10):3277-85. PubMed ID: 26758291
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A systematic review and meta-analysis of prophylactic central neck dissection on short-term locoregional recurrence in papillary thyroid carcinoma after total thyroidectomy.
    Lang BH; Ng SH; Lau LL; Cowling BJ; Wong KP; Wan KY
    Thyroid; 2013 Sep; 23(9):1087-98. PubMed ID: 23402640
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Prospective analysis of the risk factors and clinical indications of dissection of lymph node posterior to right recurrent laryngeal nerve in 283 cases of papillary thyroid carcinoma].
    Zhang P; Zhang B; Bu J; Liu Y; Zhang W
    Zhonghua Zhong Liu Za Zhi; 2014 Feb; 36(2):109-14. PubMed ID: 24796458
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of prophylactic central neck dissection in clinically node-negative differentiated thyroid cancer: assessment of the risk of regional recurrence.
    Calò PG; Lombardi CP; Podda F; Sessa L; Santini L; Conzo G
    Updates Surg; 2017 Jun; 69(2):241-248. PubMed ID: 28409443
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.